DK0506532T3 - Indolderivater, fremgangsmåde til fremstilling heraf samt lægemidler indeholdende disse - Google Patents

Indolderivater, fremgangsmåde til fremstilling heraf samt lægemidler indeholdende disse

Info

Publication number: DK0506532T3
Authority: DK; Denmark
Prior art keywords: alkyl; alkylamino; phenyl; benzyl; optionally substituted
Prior art date: 1991-03-26

Application number

DK92400764.4T

Other languages

English (en)

Inventor

Didier Festal

Robert Bellemin

Jacques Decerprit

Denis Descours

Original Assignee

Lipha

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-26

Filing date

1992-03-20

Publication date

1995-02-20

1992-03-20 Application filed by Lipha filed Critical Lipha

1995-02-20 Application granted granted Critical

1995-02-20 Publication of DK0506532T3 publication Critical patent/DK0506532T3/da

Links

229940054051 antipsychotic indole derivative Drugs 0.000 title abstract 2
150000002475 indoles Chemical class 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 5
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 4
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
125000000753 cycloalkyl group Chemical group 0.000 abstract 3
125000003342 alkenyl group Chemical group 0.000 abstract 2
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000004414 alkyl thio group Chemical group 0.000 abstract 1
230000000879 anti-atherosclerotic effect Effects 0.000 abstract 1
230000003178 anti-diabetic effect Effects 0.000 abstract 1
239000003472 antidiabetic agent Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
230000000055 hyoplipidemic effect Effects 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1
-1 polymethylene Polymers 0.000 abstract 1
125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Indole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK92400764.4T 1991-03-26 1992-03-20 Indolderivater, fremgangsmåde til fremstilling heraf samt lægemidler indeholdende disse DK0506532T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9103618A FR2674522B1 (fr)	1991-03-26	1991-03-26	Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.

Publications (1)

Publication Number	Publication Date
DK0506532T3 true DK0506532T3 (da)	1995-02-20

Family

ID=9411107

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92400764.4T DK0506532T3 (da)	1991-03-26	1992-03-20	Indolderivater, fremgangsmåde til fremstilling heraf samt lægemidler indeholdende disse

Country Status (25)

Country	Link
US (1)	US5219859A (da)
EP (1)	EP0506532B1 (da)
JP (1)	JPH0597802A (da)
KR (1)	KR950007753B1 (da)
AT (1)	ATE111078T1 (da)
AU (1)	AU658609B2 (da)
CA (1)	CA2063170A1 (da)
CS (1)	CS89592A3 (da)
DE (1)	DE69200378T2 (da)
DK (1)	DK0506532T3 (da)
ES (1)	ES2064149T3 (da)
FR (1)	FR2674522B1 (da)
HU (1)	HUT65489A (da)
IE (1)	IE65366B1 (da)
IL (1)	IL101248A (da)
MA (1)	MA22474A1 (da)
MX (1)	MX9201365A (da)
NO (1)	NO178260C (da)
NZ (1)	NZ242078A (da)
OA (1)	OA09573A (da)
RU (1)	RU2074179C1 (da)
SI (1)	SI9210305A (da)
TN (1)	TNSN92022A1 (da)
YU (1)	YU30592A (da)
ZA (1)	ZA922163B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2687402B1 (fr) *	1992-02-14	1995-06-30	Lipha	Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
EP0642498A1 (en) *	1992-05-28	1995-03-15	Pfizer Inc.	NEW $i(N)-ARYL AND $i(N)-HETEROARYLUREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A:CHOLESTEROL ACYL TRANSFERASE (ACAT)
NZ250916A (en) *	1993-02-27	1995-08-28	Nihon Nohyaku Co Ltd	N-heteroaryl-n'-phenylureas, their use as acat inhibitors
IL109568A0 (en) *	1993-05-19	1994-08-26	Fujisawa Pharmaceutical Co	Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
US5952354A (en) *	1993-07-21	1999-09-14	American Home Products Corporation	Tris carbamic acid esters: inhibitors of cholesterol absorption
DE4401893A1 (de) *	1994-01-24	1995-07-27	Bayer Ag	Substituierte Arylharnstoffe
JP3720395B2 (ja)	1994-09-20	2005-11-24	京都薬品工業株式会社	新規ヘテロ環誘導体、その製造方法およびその医薬用途
FI974437A0 (fi)	1995-06-06	1997-12-05	Pfizer	Substituoituja N-(indoli-2-karbonyyli)amideja ja johdannaisia glykogeenifosforylaasi-inhibiittoreina
KR100241643B1 (ko) *	1995-06-06	2000-03-02	디. 제이. 우드	당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체
JP3314938B2 (ja) *	1995-06-06	2002-08-19	ファイザー・インコーポレーテッド	グリコーゲンホスホリラーゼ抑制剤としての置換されたｎ−（インドール−２−カルボニル）−グリシンアミド類および誘導体
NZ299242A (en) *	1995-09-11	1997-12-19	Nihon Nohyaku Co Ltd	N-phenyl-n'-(phenyl substituted imidazol-5-yl, -oxazol-4-yl, and -thiazol-4-yl)urea derivatives
CZ292632B6 (cs) *	1995-10-05	2003-11-12	Kyoto Pharmaceutical Industries, Ltd.	Indolinový, indolový nebo tetrahydrochinolinový derivát a farmaceutický přípravek s jeho obsahem
EP0773218A1 (en) *	1995-11-13	1997-05-14	Mitsubishi Chemical Corporation	N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis
DE122010000020I1 (de) *	1996-04-25	2010-07-08	Prosidion Ltd	Verfahren zur Senkung des Blutglukosespiegels in Säugern
FR2763334A1 (fr) *	1997-05-13	1998-11-20	Lipha	Derives anthraniliques
WO1999031075A1 (en) *	1997-12-16	1999-06-24	Warner-Lambert Company	1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
KR20010033153A (ko) *	1997-12-16	2001-04-25	로즈 암스트롱, 크리스틴 에이. 트러트웨인	4(3)-치환-4(3)-아미노메틸-(티오)피란 또는 -피페리딘유도체(=가바펜틴 동족체), 그의 제법 및 신경 질환 치료용도
ES2216338T3 (es) *	1997-12-16	2004-10-16	Warner-Lambert Company Llc	Aminas novedosas como agentes farmaceuticos.
SK282727B6 (sk)	1997-12-19	2002-11-06	Slovakofarma, A. S.	1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
US6277877B1 (en)	2000-08-15	2001-08-21	Pfizer, Inc.	Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
EP1349858B1 (en)	2000-11-02	2008-08-27	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
JP2005538047A (ja) *	2002-05-03	2005-12-15	ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー	ボンベシンアンタゴニスト
EP1541553B1 (en) *	2002-07-17	2010-06-02	Kyoto Pharmaceutical Industries, Ltd.	Indoline compound and medicinal use thereof
US7595403B2 (en)	2003-04-01	2009-09-29	Eli Lilly And Company	Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
NZ544803A (en) *	2003-08-29	2009-11-27	Kowa Co	Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
AU2006319231A1 (en)	2005-11-30	2007-06-07	F. Hoffmann-La Roche Ag	3-amino-1-arylpropyl indoles and aza-substituted indoles
JP2009517432A (ja)	2005-11-30	2009-04-30	エフ．ホフマン−ラロシュアーゲー	３−アミノ−２−アリールプロピルアザインドールおよびその使用
RU2361581C2 (ru) *	2007-09-14	2009-07-20	Закрытое Акционерное Общество "Мастерклон"	Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
SK287385B6 (sk)	2007-11-27	2010-08-09	Hameln-Rds, A. S.	1,3-Disubstituované močoviny, spôsob ich prípravy a použitia
CN104628621A (zh) *	2015-01-22	2015-05-20	湖南华腾制药有限公司	一种氟取代吲哚衍生物的制备方法
WO2018064465A1 (en)	2016-09-29	2018-04-05	The Regents Of The University Of California	Compounds for increasing neural plasticity
CU20190106A7 (es)	2017-06-26	2020-11-30	Lunella Biotech Inc	Mitocetoscinas: agentes terapéuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en células cancerosas
JP7770673B2 (ja)	2019-02-27	2025-11-17	ザリージェンツオブザユニバーシティオブカリフォルニア	脳障害を治療するためのアゼピノ－インドール及び他の複素環化合物
AU2022416279A1 (en)	2021-12-15	2024-07-25	Delix Therapeutics, Inc.	Phenoxy and benzyloxy substituted psychoplastogens and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS55151505A (en) *	1979-05-14	1980-11-26	Kuraray Co Ltd	Indole agricultural and horticultural fungicide
CA1299174C (en) *	1987-02-02	1992-04-21	Michael Edward Flaugh	Alkylmelatonins
EP0375133A1 (en) *	1988-11-14	1990-06-27	The Upjohn Company	Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
IL95584A (en) *	1989-09-07	1995-03-15	Abbott Lab	Indole-, benzoporene- and benzothiophene compounds including lipoxygenase-inhibiting compounds and pharmaceutical compounds containing them
WO1991004027A1 (en) *	1989-09-15	1991-04-04	Pfizer Inc.	New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
EP0471296B1 (en) *	1990-08-13	1995-11-08	Hoechst-Roussel Pharmaceuticals Incorporated	1-(Pyridinylalkyl)-1H-indoles, indolines and related analogs
FR2680366B1 (fr) *	1991-08-13	1995-01-20	Adir	Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
WO1993005020A1 (en) *	1991-09-06	1993-03-18	Merck & Co., Inc.	Indoles as inhibitors of hiv reverse transcriptase

1991
- 1991-03-26 FR FR9103618A patent/FR2674522B1/fr not_active Expired - Fee Related
1992
- 1992-03-16 IL IL10124892A patent/IL101248A/en not_active IP Right Cessation
- 1992-03-17 CA CA002063170A patent/CA2063170A1/en not_active Abandoned
- 1992-03-20 AU AU13094/92A patent/AU658609B2/en not_active Ceased
- 1992-03-20 US US07/855,544 patent/US5219859A/en not_active Expired - Fee Related
- 1992-03-20 AT AT92400764T patent/ATE111078T1/de active
- 1992-03-20 NZ NZ242078A patent/NZ242078A/en unknown
- 1992-03-20 DK DK92400764.4T patent/DK0506532T3/da active
- 1992-03-20 ES ES92400764T patent/ES2064149T3/es not_active Expired - Lifetime
- 1992-03-20 DE DE69200378T patent/DE69200378T2/de not_active Expired - Fee Related
- 1992-03-20 EP EP92400764A patent/EP0506532B1/fr not_active Expired - Lifetime
- 1992-03-23 MA MA22763A patent/MA22474A1/fr unknown
- 1992-03-24 IE IE920937A patent/IE65366B1/en not_active IP Right Cessation
- 1992-03-24 NO NO921141A patent/NO178260C/no unknown
- 1992-03-25 ZA ZA922163A patent/ZA922163B/xx unknown
- 1992-03-25 HU HU9200997A patent/HUT65489A/hu unknown
- 1992-03-25 JP JP4067252A patent/JPH0597802A/ja active Pending
- 1992-03-25 RU SU925011235A patent/RU2074179C1/ru active
- 1992-03-25 CS CS92895A patent/CS89592A3/cs unknown
- 1992-03-26 KR KR1019920005020A patent/KR950007753B1/ko not_active Expired - Fee Related
- 1992-03-26 OA OA60177A patent/OA09573A/fr unknown
- 1992-03-26 SI SI9210305A patent/SI9210305A/sl unknown
- 1992-03-26 YU YU30592A patent/YU30592A/sh unknown
- 1992-03-26 TN TNTNSN92022A patent/TNSN92022A1/fr unknown
- 1992-03-26 MX MX9201365A patent/MX9201365A/es not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69200378T2 (de)	1995-03-09
FR2674522B1 (fr)	1993-07-16
NO178260C (no)	1996-02-21
JPH0597802A (ja)	1993-04-20
AU1309492A (en)	1992-10-01
OA09573A (fr)	1993-01-31
ATE111078T1 (de)	1994-09-15
HUT65489A (en)	1994-06-28
KR920018022A (ko)	1992-10-21
IE65366B1 (en)	1995-10-18
IL101248A (en)	1996-12-05
EP0506532B1 (fr)	1994-09-07
MX9201365A (es)	1992-10-01
MA22474A1 (fr)	1992-10-01
ZA922163B (en)	1993-09-27
TNSN92022A1 (fr)	1993-06-08
NO921141D0 (no)	1992-03-24
HU9200997D0 (en)	1992-05-28
IL101248A0 (en)	1992-11-15
AU658609B2 (en)	1995-04-27
EP0506532A1 (fr)	1992-09-30
SI9210305A (en)	1996-02-29
IE920937A1 (en)	1992-10-07
NO921141L (no)	1992-09-28
NZ242078A (en)	1994-10-26
YU30592A (sh)	1994-12-28
CA2063170A1 (en)	1992-09-27
RU2074179C1 (ru)	1997-02-27
KR950007753B1 (ko)	1995-07-14
ES2064149T3 (es)	1995-01-16
FR2674522A1 (fr)	1992-10-02
DE69200378D1 (de)	1994-10-13
CS89592A3 (en)	1992-10-14
NO178260B (no)	1995-11-13
US5219859A (en)	1993-06-15

Publication	Publication Date	Title
NO178260C (no)	1996-02-21	Indolderivater, mellomproduktforbindelser for deres fremstilling, anvendelse derav samt farmasöytisk preparat
DK0737685T3 (da)	2000-10-09	Pyrinderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger, der indeholder disse
DK0557171T3 (da)	1995-12-04	Azaindoler, fremgangsmåde til deres fremstilling samt lægemidler indeholdende dem
PT96255A (pt)	1991-09-30	Processo para a preparacao de novos derivados da 1-naftil-piperazina
DK0662471T3 (da)	1998-12-21	Naphthalenderivater med affinitet over for melatonin-receptorer, fremgangsmåde til deres fremstilling og farmaceutiske samm
NO991637L (no)	1999-06-07	Aminotiazolderivater, fremgangsmÕte ved fremstilling derav og farmas°ytiske blandinger inneholdende disse
DK0679630T3 (da)	1999-01-18	Bicykliske-aromatiske forbindelser, farmaceutiske og kosmetiske præparater indeholdende disse samt anvendelser
DE3763412D1 (de)	1990-08-02	Neue silanderivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schaedlingsbekaempfungsmittel.
DK452687D0 (da)	1987-08-28	Dihydropyridinforbindelser, isomere, isomerblandinger, optiske antipoder og racemater deraf, deres fremstilling og anvendelse som laegemidler
NO20033718D0 (no)	2003-08-21	Syntetiske humane peptider og farmasöytiske sammensetninger omfattende disse for behandling av systemisk lupus erythematosus
NO304375B1 (no)	1998-12-07	Nye 2-sakkarinylmetylarylkarboksylater som er nyttige som inhibitorer for proteolytiske enzymer, preparater og anvendelse derav
DK406587A (da)	1988-02-05	1,4-dihydropyridinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK422688D0 (da)	1988-07-28	Substituerede pyridylethanolaminer og fysiologisk acceptable salte og n-oxider deraf, deres fremstilling og anvendelse samt mellemprodukter og disses fremstilling
DK74185D0 (da)	1985-02-15	3-phenyl-2-propen-amin-derivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
DK0658557T3 (da)	1999-05-31	Eburnan-derivater, fremgangsmåde til fremstilling af sådanne derivater og farmaceutiske sammensætninger indeholdende disse
PT916671E (pt)	2002-06-28	Novos inibidores de metaloproteases processo para a sua preparacao e as suas composicoes farmaceuticas que os contem
ATE150014T1 (de)	1997-03-15	Perhydroisoindol-derivate, deren herstellung und die sie behaltende pharmazeutische zusammenfassungen
MXPA04011363A (es)	2005-02-14	Nuevos derivados acil hidrazino del tiofeno, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion.
DK0816359T3 (da)	2005-03-14	4-amino-2-ureido-pyrimidin-5-carboxylsyreamider, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
FI860443A0 (fi)	1986-01-30	5-sulfonamido-1-aryl-pyrazoler.
FR2800373B1 (fr)	2001-12-07	Procede de preparation d'oxazoles trisubstitues
DK0625973T3 (da)	1996-06-10	Fremgangsmåde til fremstilling af derivater af 2-amino-4-nitrobenzothiazol og derved anvendte mellem produkter